SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-184603"
 

Search: onr:"swepub:oai:DiVA.org:uu-184603" > Intranasal Treatmen...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Chapman, Colin DUppsala universitet,Funktionell farmakologi (author)

Intranasal Treatment of Central Nervous System Dysfunction in Humans

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2012-11-08
  • Springer Science and Business Media LLC,2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-184603
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-184603URI
  • https://doi.org/10.1007/s11095-012-0915-1DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:for swepub-publicationtype

Notes

  • One of the most challenging problems facing modern medicine is how to deliver a given drug to a specific target at the exclusion of other regions. For example, a variety of compounds have beneficial effects within the central nervous system (CNS), but unwanted side effects in the periphery. For such compounds, traditional oral or intravenous drug delivery fails to provide benefit without cost. However, intranasal delivery is emerging as a noninvasive option for delivering drugs to the CNS with minimal peripheral exposure. Additionally, this method facilitates the delivery of large and/or charged therapeutics, which fail to effectively cross the blood-brain barrier (BBB). Thus, for a variety of growth factors, hormones, neuropeptides and therapeutics including insulin, oxytocin, orexin, and even stem cells, intranasal delivery is emerging as an efficient method of administration, and represents a promising therapeutic strategy for the treatment of diseases with CNS involvement, such as obesity, Alzheimer's disease, Parkinson's disease, Huntington's disease, depression, anxiety, autism spectrum disorders, seizures, drug addiction, eating disorders, and stroke.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Frey, William H (author)
  • Craft, Suzanne (author)
  • Danielyan, Lusine (author)
  • Hallschmid, Manfred (author)
  • Schiöth, Helgi BUppsala universitet,Funktionell farmakologi(Swepub:uu)helgschi (author)
  • Benedict, ChristianUppsala universitet,Funktionell farmakologi(Swepub:uu)chrbe136 (author)
  • Uppsala universitetFunktionell farmakologi (creator_code:org_t)

Related titles

  • In:Pharmaceutical research: Springer Science and Business Media LLC30:10, s. 2475-24840724-87411573-904X

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view